Search results for: 'Preferred Destination for Early Phase Clinical Trials'
- Did you mean
- preferred desalination for earth paas clinical trials
- preferred desalination for earth phone clinical trials
- Related search terms
- clinical laboratories service market
- forces managed security services market study
- clinical communications market research
- clinical environment market size ® invest 2025
- clinical environment market size ® invest 2020
-
11 Jun 2014  |  Global  |  Market Research
Analysis of the Western European Next Generation Sequencing (NGS) Market
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 May 2014  |  Asia Pacific  |  Market Research
Russia In Vitro Diagnostics (IVD) Market Data
Early Detection Provides New Opportunities for IVD Industry
This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market reve...
$3,950.00
Special Price $2,962.50 save 25 %
-
02 May 2014  |  North America  |  Market Research
US In Vitro Diagnostics (IVD) Market Data
Early Detection Provides New Opportunities for the IVD Industry
This study provides data for the US in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose, and immunochemistry are the segments in this market. Market revenues have been included in this de...
$3,950.00
Special Price $2,962.50 save 25 %
-
05 May 2014  |  North America  |  Market Research
Global Regenerative Medicine Market
A New Era in Human Health to Resolve Unmet Medical Needs
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...
$3,950.00
Special Price $2,962.50 save 25 %
-
20 Nov 2014  |  North America  |  Market Research
Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Launch of Novel Oral Therapies to Result in Major Market Changes
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...
$3,950.00
Special Price $2,962.50 save 25 %
-
20 Jun 2014  |  Global  |  Market Research
Global Next-generation Sequencing Market
On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point
The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research ser...
$10,000.00
Special Price $7,500.00 save 25 %
-
16 Jan 2014  |  Global  |  Market Research
Analysis of the Global Biosimilars Market
Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth
Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline asse...
$10,000.00
Special Price $7,500.00 save 25 %
-
19 Sep 2014  |  North America  |  Market Research
A Product and Pipeline Analysis of the Global Knee Cartilage Repair Market
A New Standard of Care May be on the Horizon
The standard of care, microfracture, does not fulfill long-term needs for patients with chondral defects. In addition, current alternative treatment options are plagued by multiple challenges and limitations. This research service focuses on medicine in the knee cartilage repair market, providing a detailed overview of 9 key products. A product an...
$5,000.00
Special Price $3,750.00 save 25 %
-
04 Feb 2014  |  North America  |  Market Research
Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market
This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...
$3,950.00
Special Price $2,962.50 save 25 %
-
10 Nov 2014  |  North America  |  Market Research
A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market
Launch of Several Pipeline Oral Products Could Diminish the Market for Injectable Therapies
This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...
$3,950.00
Special Price $2,962.50 save 25 %